机构:
Univ Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USAUniv Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA
Baccaglini, L.
[1
]
Thongprasom, K.
论文数: 0引用数: 0
h-index: 0
机构:
Chulalongkorn Univ, Dept Oral Med, Fac Dent, Bangkok, ThailandUniv Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA
Thongprasom, K.
[2
]
论文数: 引用数:
h-index:
机构:
Carrozzo, M.
[3
]
Bigby, M.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA
Beth Israel Deaconess Med Ctr, Boston, MA 02215 USAUniv Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA
Bigby, M.
[4
,5
]
机构:
[1] Univ Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA
[2] Chulalongkorn Univ, Dept Oral Med, Fac Dent, Bangkok, Thailand
[3] Newcastle Univ, Dept Oral Med, Ctr Oral Hlth Res, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England
[4] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
Lichen planus (LP) is a common disorder affecting the oral cavity (OLP) and skin. Despite intensive research, LP/OLP etiology and treatment remain controversial. We investigated four controversial topics: (i) Is hepatitis C virus (HCV) infection associated with LP and involved in its pathogenesis? (ii) Should all patients with LP be screened for HCV? (iii) Should patients with OLP have all their amalgam restorations removed? (iv) Are there any new treatments for OLP? Results from extensive literature searches suggested that: (i) Robust evidence from three meta-analyses indicate that HCV is associated with LP and might be involved in OLP pathogenesis (ii) It would be prudent to screen patients with LP/OLP at significant risk with an ELISA for HCV antibodies using country-specific screening strategies (iii) There is no evidence that either OLP or oral lichenoid lesions patients would routinely benefit from having all their amalgam restorations replaced. Weak evidence from potentially very biased, small, non-randomized, unblinded studies suggests that a small fraction of patients may benefit from targeted amalgam replacement. (iv) There is weak evidence that, among new OLP treatments, topical pimecrolimus, aloe vera, and oral curcuminoids may be useful. The development of specific formulations for oral delivery of topical medications is a promising field. Oral Diseases (2013) 19, 128-143